Here, we established a genome-wide CRISPR knockout screening in CD24+CD133+ liver CSCs and identified the H3K4 methyltransferase SET domain containing 1A (SETD1A) as a critical diver for HCC stemness and progression, providing a therapeutic target for HCC treatment. This evidence concerns the gene CD24 and hepatocellular carcinoma.